CROs & Sponsors: Have we overcome the limitations of early site payment solutions? Learn how a Site Payment Advisory Group helped improve site payment technology for all stakeholders.
Raise your hand if you are a sponsor/CRO that wants to be the organization of choice for investigative sites. Now, raise your hand if you put your sites through endless hours of Web or e-learning training as part of the study start-up process. This is just one of several surefire ways to kill a site’s enthusiasm and commitment to working with you or on your studies. Another, for the record, is sending ill-prepared clinical research associates (CRAs) who are not training specialists to do the PowerPoint death march at site initiation visits (SIVs)!
Recently a clinical research associate (CRA) candidate I’ll call Evan approached our firm for assistance in finding a new assignment. His resume was impressive, representing strong foundations as a study coordinator with over 10 years of experience as a CRA for highly reputable CROs.
Most of us have spoken to someone and struggled to understand an accent or word choice. Even within a country, different regions can have unique language. So how do you coordinate complex projects across countries and regions, accounting for the differences in culture and honoring common objectives?
How a CRO's decision to automate site payments saved thousands.
How automating site grant payments can optimize payment processes for sites leading to greater site satisfaction and allowing sites to operate at peak performance and reduce errors.
Southeastern Nephrology Associates (SENA) have been providing high quality nephrology, kidney dialysis, kidney transplant and hypertension care for patients since 1975.
ClinCard is designed to optimize clinical trial performance by improving patient engagement and retention and eliminating the administrative burdens that can distract from research execution.
Site payments are not easy. They are frustrating, burdensome and a drain of time and resources. A site’s inability to receive payment accurately and quickly is the result of manual, siloed processes across the entire study.
A full-service, highly qualified partner who uses effective technology-enabled financial management services can help ensure efficient site payments, greater transparency into payments on all sides, and satisfied investigators.
BioClinica, Inc. a global provider of clinical trial management solutions, recently announced that members of its team will attend, participate in, and speak at several upcoming industry conferences in April, May, and June.
CFS Clinical (CFS), a specialty provider focused on the business and financial management activities for clinical trials, recently announced the launch of its upgraded technology platform and new tax consulting services.
Stiris Research has entered into a strategic partnership with Statistics & Data Corporation (SDC) to offer seamless implementation of full-service Clinical + Biostatistics and Data Management/EDC solutions.
Accelovance, an award-winning clinical services company, announced recently the addition of Stephan A. Bart Sr., MD as Chief Medical Officer for the organization.
CRA Holdings, LLC announced recently that it has acquired Radiant Research, Inc. CRA Holdings is the company that also owns Clinical Research Advantage (CRA), another major player in the SMO market.
CFS Clinical (CFS), a specialty provider focused on the business and financial management activities for clinical trials, has been selected by the Philadelphia Business Journal as one of the region’s Best Places to Work.
Darlene Panzitta, President and Founder of DSP Clinical, is among this year's PharmaVOICE 100 List of the most influential people in lifes sciences industries.
CFS Clinical (CFS), a specialty provider focused on the business and financial management activities for clinical trials, is pleased to announce the launch of our revolutionary technology platform — CFS InSite, which supports all of the company’s services.
Clinical Financial Services (CFS), a specialty provider focused on the business and financial management activities for clinical trials, announces its new name and brand image.